HLL Lifecare Pays Record ₹69.53 Crore Dividend to Government of India

HLL Lifecare Limited (HLL), a Mini-Ratna Central Public Sector Undertaking (CPSU) under the Ministry of Health & Family Welfare, Government of India, has further reinforced its leadership in public healthcare by paying a record dividend of ₹69.53 crore to the Government of India for the financial year 2024–25 — one of the highest ever in the company’s history.

The dividend cheque was presented to J.P. Nadda, Union Minister of Health & Family Welfare, by Dr. Anitha Thampi, Chairperson, HLL, in the presence of Anupriya Patel, Minister of State for Health & Family Welfare; Punya Salila Srivastava, Union Health Secretary; Hovyeda Abbas, AS&FA; and Vijay Nehra, Joint Secretary, Ministry of Health & Family Welfare. Senior HLL officials including N. Ajit, Director (Marketing), and Ramesh P, Director (Finance), were also present.

“HLL is a Reliable Hand in the Medical Health Services” — J.P. Nadda

Speaking on the occasion, Nadda praised HLL’s exemplary contribution to India’s healthcare delivery ecosystem, calling it “a reliable hand in the field of medical services.” He emphasized that HLL remains firmly aligned with the national vision of accessible, affordable, and quality healthcare for all.

Commending the company’s strong performance, the Minister said, “HLL, along with its subsidiaries and Amrit Pharmacies, has emerged as a key player in transforming the health sector. In the last 10 years, over 6.7 crore people have benefited through affordable medicines from Amrit Pharmacies, saving more than ₹8,000 crore in out-of-pocket expenditure.”

Strong Financial Growth in FY 2024–25

HLL reported revenue from operations of ₹4,500 crore in FY 2024–25, marking a 20% growth over the previous year. The company’s net worth rose to ₹1,100 crore as on March 31, 2025, reflecting its strong financial stability and performance across manufacturing and service sectors.

On a consolidated basis, including subsidiaries HITES, GAPL, and Lifespring Hospitals, the HLL Group achieved a total revenue of ₹4,900 crore, representing a 19% year-on-year growth.

A Pillar of Public Health Infrastructure

As a trusted arm of the Ministry of Health & Family Welfare, HLL Lifecare continues to play a crucial role in ensuring equitable access to healthcare products and services. Its operations span manufacturing of contraceptives, blood bags, diagnostic kits, and hospital services, alongside key public health initiatives through its subsidiaries and Amrit Pharmacies.